Stathmin 1 expression in neuroendocrine and proliferating prostate cancer
Abstract Prostate cancer (PCa) is the second leading cause of cancer-related mortality among men in the United States. While PCa initially responds to androgen deprivation therapy, a significant portion progresses to castration-resistant PCa. Approximately 20–25% of these cases acquire aggressive ne...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer
2025-01-01
|
| Schriftenreihe: | Discover Oncology |
| Online-Zugang: | https://doi.org/10.1007/s12672-025-01754-6 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|